ArticlemAbs
Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.
Silvia Calpe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
cites it